Infinity Pharmaceuticals | INFI - Debt


Infinity Pharmaceuticals reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 54.6B 17M Dec/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.5B 3.6M Dec/2025
Gilead Sciences USD 24.94B 5M Dec/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Grifols EUR 9.23B 626.05M Dec/2024
Incyte USD 39.43M 982K Mar/2026
Infinity Pharmaceuticals USD 0 0 Jun/2022
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
J&J USD 47.93B 2.14B Dec/2025
Novartis USD 47B 11.62B Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 253.71M 8.37M Dec/2025